WB approves to loan $500m for vaccination in Bangladesh
[content-egg module=AE__amazoncom]
The funds came in support of the government’s prioritised plan of covering 40 percent of the population in the first phase of vaccination.
“Bangladesh has taken quick action to combat COVID-19 by rolling out a national vaccination program. To achieve the objectives of the program, fast and equitable access to vaccines will be important,” said Mercy Tembon, World Bank’s country director for Bangladesh. “This financing will help Bangladesh strengthen its national systems to ensure the prompt delivery of vaccines to one-third of its population.”
The project will continue to provide support to strengthen the national health systems to detect, prevent, and treat COVID-19 cases, as well as prepare for future health emergencies. Further, it will provide training to personnel for a successful vaccination program and strengthen the capacity of the Directorate General of Drug Administration for testing vaccines in the country.
The financing will cover the cost of deployment of the vaccines acquired through the COVID-19 Vaccine Global Access Facility (COVAX) for about 20 percent of the population.
For the remaining 11 percent of the population, the financing will cover direct purchases of vaccines from manufacturers or through COVAX, and the costs related to administering the vaccination. In parallel, the government is purchasing vaccines using its own resources that will cover another 9 percent of the population.